1,4,6- androstatrien-3,17-dione: Difference between revisions
Jump to navigation
Jump to search
m (Protected "1,4,6- androstatrien-3,17-dione": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 34: | Line 34: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
==Further Reading== | ==Further Reading== | ||
Latest revision as of 13:46, 4 September 2012
This article needs attention from an expert in Pharmacology. |
Template:Deadend 1,4,6- androstatrien-3,17-dione, also known as ATD is an aromatase inhibitor used to control estrogen synthesis.[1]
1,4,6- androstatrien-3,17-dione is used in over-the-counter bodybuilding supplements such as Rebound XT, Novedex XT and Inhibit-E, and while not banned, may cause positive urinanalysis results leading to disqualification from competitive sports due it's similar properties to banned substances.[2]
References
- ↑ Adkins-Regan, Elizabeth (2006-07-06). "Sex steroids modulate changes in social and sexual preference during juvenile development in zebra finches". Hormones and Behaviour. Elsevier Inc. 50 (5): 772–778. Retrieved 2007-10-07. Unknown parameter
|coauthors=ignored (help) - ↑ "DRUG TESTING" (HTML). Organization of Competitive Bodybuilders. Retrieved 2007-10-07.
Further Reading
- ^ Covey DF, Hood WF. (1981). "Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity". Endocrinology 108 (4): 1597-9. PMID 7472286.